Diseases of the blood and hematopoietic system (haematological)
Welcome to licensed pharmacies in Poland:
Non-prescription medicines delivery across Europe.
Frequently ordered: potency boosters (sildenafil OTC), quit smoking aids.
Is Neoparin 80mg twice a day dose safe for me at 70 years old, weighing 60 kg?
I have varicose veins. Dr. prescribed neoparin 2 times a day at a dose of 80mg. I weigh about 60kg. I'm 70 years old. Is the dosage safe?
NeoparinAnticoagulantsContraception and thrombosis - what are the risks?Diseases of the blood and hematopoietic system (haematological)Guide to anticoagul medicinesSepsisWhat does pain in the groin mean?
1 answer
* required field
You can drag the photo file here.
* required field
Notify of a new answer.
Other messages will not be sent.
Other messages will not be sent.
Suggested Products
Space for your product
Anna Lewandowska Pharmacist, Editor
10 months ago
Neoparin, which contains enoxaparin sodium, is a medicine used to prevent and treat thromboembolism. Its use in the elderly, including patients over 70 years of age, requires special caution.
A dose of Neoparin 80 mg twice a day is typically used to treat phlebitis, but its safety depends on individual factors such as general health and possible co-existing medical conditions. For the elderly and those with kidney or liver disease, the dosage may need to be adjusted.
If you have any further doubts, it is worth consulting your attending physician. If you are unable to consult your doctor, you can use the teleconsultation here:
https://www.gdziepolek.pl/telekonsultacja/
The availability of Neoparin in pharmacies in Polish can be checked at the following address:
https://www.gdziepolek.pl/produkty/92384/neoparin-iniekcja/apteki
Appreciate the answerer and highlight the question on the home page
User questions and answers that provide feedback about products are not verified for the purchase or use of the product. Companies often order anonymous comments to form positive opinions about their products, or negative ones about competitors. Therefore, be guided by the information in the pharmacists' responses in the first place.